VCEL Vericel Corporation

16.32
+0.73  (+5%)
Previous Close 15.59
Open 15.8
Price To Book 8.12
Market Cap 720,314,143
Shares 44,136,896
Volume 495,282
Short Ratio
Av. Daily Volume 489,221

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

BLA filing due 2Q 2020.
NexoBrid
Severe burns
Phase 2b topline data released March 2016. Full data released April 2016
ixmyelocel-T
Stem cells - Dilated Cardiomyopathy
FDA Approval announced December 13, 2016 ahead of PDUFA date of January 3 2017.
MACI
Focal chondral cartilage defects in the knee.

Latest News

  1. Edited Transcript of VCEL earnings conference call or presentation 6-Aug-19 12:00pm GMT
  2. Vericel (VCEL) Q2 2019 Earnings Call Transcript
  3. Is Vericel (NASDAQ:VCEL) A Risky Investment?
  4. Vericel Reports Second Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
  5. Vericel to Present at the 39th Annual Canaccord Genuity Growth Conference on Thursday, August 8, 2019
  6. Vericel to Report Second-Quarter 2019 Financial Results on August 6, 2019
  7. Edited Transcript of VCEL earnings conference call or presentation 7-May-19 12:00pm GMT
  8. Introducing Vericel (NASDAQ:VCEL), The Stock That Soared 736% In The Last Three Years
  9. Loss-Making Vericel Corporation (NASDAQ:VCEL) Expected To Breakeven
  10. Hedge Funds Have Never Been This Bullish On Vericel Corp (VCEL)
  11. BARDA to Fund NexoBrid Expanded Access Treatment Protocol for Thermal Burns
  12. Vericel to Present at the 2019 UBS Global Healthcare Conference on Wednesday, May 22, 2019
  13. Surgeons to use product from Cambridge's Vericel on baby born without skin
  14. Were Hedge Funds Right About Dumping Vericel Corp (VCEL) ?
  15. Vericel looks to market a gel for burns with new $142M licensing deal
  16. Vericel Reports First Quarter 2019 Financial Results and Raises Full Year 2019 Revenue Guidance
  17. MediWound Enters into Exclusive License Agreement with Vericel for Commercial Rights to NexoBrid® in North America
  18. Vericel Enters into Exclusive License Agreement with MediWound for North American Rights to NexoBrid, a Biological Orphan Product for Debridement of Severe Thermal Burns
  19. Calculating The Intrinsic Value Of Vericel Corporation (NASDAQ:VCEL)